Histopathologically dysplastic neurofibromas in neurofibromatosis 1: Diagnostic criteria, prevalence and clinical significance

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 1008-1012

  Valeyrie Allanore, L ^a   Ortonne, N ^a   Lantieri, L ^a   Ferkal, S ^a   Wechsler, J ^a   Bagot, M ^a   Wolkenstein, P ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Cytonuclear atypia; Dysplastic neurofibroma; Hypercellularity; Malignant peripheral nerve sheath tumours; Neurofibromatosis 1

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NEUROFIBROMA, PLEXIFORM; NEUROFIBROMATOSIS 1; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; SUBCUTANEOUS TISSUE;

EID: 42049094230     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08494.x     Document Type: Article

References (16)

1. Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999 89 : 1 6.
2. Cawthon RM, Weiss R, Xu G et al. A major segment of neurofibromatosis type 1 gene. Cell 1990 62 : 193 201.
3. Wallace MR, Marchuk DA, Andersen LB et al. Type 1 neurofibromatosis gene. Science 1990 249 : 181 6.
4. DeBella K, Szudek J, Friedman JM. Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 2000 105 : 608 14.
5. Ferner RE, Gutman DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002 62 : 1573 7.
6. Evans DG, Baser ME, Mc Ganghran J et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002 39 : 311 14.
7. Tucker T, Wolkenstein P, Revuz J et al. Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology 2005 65 : 205 11.
8. Khosrotehrani K, Bastuji-Garin S, Riccardi VM et al. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients. Am J Med Genet A 2005 132 : 49 53.
9. Khosrotehrani K, Bastuji-Garin S, Zeller J et al. Clinical risk factors for mortality in patients with neurofibromatosis 1. A cohort study of 378 patients. Arch Dermatol 2003 139 : 187 91.
10. Valeyrie-Allanore L, Ismaïli N, Bastuji-Garin S et al. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. Br J Dermatol 2005 153 : 79 82.
11. King AA, Debaun MR, Riccardi VM, Gutmann DH. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 2000 93 : 388 92.
12. Friedman JM, Birch P, Greene C. National Neurofibromatosis Foundation International Database. Am J Med Genet 1993 45 : 88 91.
13. Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1728 patients. Am J Med Genet 1997 70 : 138 43.
14. Coindre JM, Trojani M, Contesso G et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986 58 : 306 8.
15. Levy P, Bieche I, Leroy K et al. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Clin Cancer Res 2004 10 : 3763 71.
16. Levy P, Vidaud D, Leroy K et al. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Mol Cancer 2004 3 : 20.